Application based on the pivotal Phase 3 TRANSFORM study in which Breyanzi showed significant and clinically meaningful improvements over salvage chemotherapy followed by high-dose chemotherapy plus autologous stem cell transplant, which has been the standard of care for more than 20 years
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers
For patients with resectable early-stage gastric and gastroesophageal junction cancers
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
First pivotal Phase 3 trial to show superiority of Keytruda plus a TROP2 antibody-drug conjugate, Trodelvy, versus standard of care in first-line metastatic TNBC
Subscribe To Our Newsletter & Stay Updated
